Finance

Lists
HIMS:NYSE
Hims & Hers Health Inc
US$ २९.५४
-०.५१%
(-०.१५) 1D
अक्टोबर ६, ११:२५:५४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
US$ ३०.०८
High
US$ ३०.०८
Low
US$ २९.०७
Mkt. cap
६.७४ अरब
Avg. vol.
९८.२३ लाख
Volume
३६.३० लाख
52-wk high
US$ ६५.३०
52-wk low
US$ १३.७४
EPS
-US$ ०.६३
Beta
२.४४
Shares outstanding
२२.४९ करोड
No. of employees
२ हजार
Open
US$ ३०.०८
High
US$ ३०.०८
Low
US$ २९.०७
Mkt. cap
६.७४ अरब
Avg. vol.
९८.२३ लाख
Volume
३६.३० लाख
52-wk high
US$ ६५.३०
52-wk low
US$ १३.७४
EPS
-US$ ०.६३
Beta
२.४४
Shares outstanding
२२.४९ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees२.४४ हजार
Foundedनोभेम्बर २०१७
Headquartersसान फ्रान्सिस्को, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitehims.com
Analyst ratings
Based on 14 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
11
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current US$ २९.५४
US$ ४२.०० (+४२.१८%)
Average
US$ ३२.८२ (+११.१०%)
Lowest
US$ २६.०० (-११.९८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Hold
Reiterated
US$ ३२.००
+८.३%
09/25/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
US$ ३२.००
+८.३%
09/11/2026
Bryan Smilek
J.P. Morgan
Hold
Initiated
US$ ३२.००
+८.३%
09/11/2026
Brian Tanquilut
Jefferies
Hold
Maintained
US$ ३१.००
+४.९%
09/03/2026
Justin Patterson
KeyBanc
Hold
Maintained
-
-
09/02/2026
Glen Santangelo
Barclays
Buy
Reiterated
US$ ३५.००
+१८.५%
08/20/2026
George Hill
Deutsche Bank
Hold
Reiterated
US$ २६.००
-१२%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
US$ ३०.००
+१.६%
08/11/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
US$ २८.००
-५.२%
08/11/2026
Maria Ripps
Canaccord Genuity
Buy
Reiterated
US$ ४०.००
+३५.४%
08/11/2026
Ryan MacDonald
Needham
Buy
Reiterated
US$ ४२.००
+४२.२%
08/11/2026
David Larsen
BTIG
Hold
Reiterated
-
-
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
US$ ३३.००
+११.७%
08/12/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
-
-
08/11/2026
Oliver Chen
TD Cowen
Hold
Reiterated
US$ २५.००
-१५.४%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
US$ ३३.००
+११.७%
05/12/2026
Michael Cherny
Leerink Partners
Hold
Maintained
-
-
04/16/2026
Unknown Analyst
Nephron
Buy
Upgraded
US$ ३५.००
+१८.५%
03/09/2026
Last report
२०२६ अगस्ट १०
Fiscal period
Q2 2026
EPS / Est. (USD)
-US$ ०.०९ / US$ ०.०९
-१९८.२२%miss
Revenue / Est. (USD)
७५.३२ करोड / ७३.०१ करोड
+३.१६%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
५९.९० करोड
६१.७८ करोड
६०.८१ करोड
७५.३२ करोड
Cost of goods sold
१५.६९ करोड
१७.३४ करोड
१८.२८ करोड
२७.२४ करोड
Cost of revenue
१५.६९ करोड
१७.३४ करोड
१८.२८ करोड
२७.२४ करोड
Research and development expenses
४.०६ करोड
४.१० करोड
४.६९ करोड
५.४९ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३८.९७ करोड
३८.६६ करोड
४२.६४ करोड
५२.१९ करोड
Operating expense
४३.०३ करोड
४२.७६ करोड
४७.३३ करोड
५७.६८ करोड
Total operating expenses
५८.७२ करोड
६०.१० करोड
६५.६१ करोड
८४.९३ करोड
Operating income
१.१८ करोड
१.६८ करोड
-४.८० करोड
-९.६० करोड
Other non operating income
-५९.९२ लाख
-५.७५ लाख
-१.८६ करोड
-२४.३२ लाख
EBT including unusual items
१.२२ करोड
१.८४ करोड
-१०.१६ करोड
-९.२६ करोड
EBT excluding unusual items
१.२२ करोड
२.१६ करोड
-६.१६ करोड
-९.६२ करोड
Income tax expense
-३५.५१ लाख
-२२.४८ लाख
-९४.३६ लाख
-६३.४३ लाख
Effective tax rate
-२९.०५%
-१२.२५%
९.२९%
६.८५%
Other operating expenses
-
-
-
-
Net income
१.५८ करोड
२.०६ करोड
-९.२१ करोड
-८.६३ करोड
Net profit margin
२.६३%
३.३३%
-१५.१५%
-११.४६%
Earnings per share
०.२८
०.२२
-०.१९
-०.०९
Interest and investment income
८०.०८ लाख
६८.०५ लाख
७९.०० लाख
६०.०० लाख
Interest expense
-१६.०० लाख
-१५.०० लाख
-२८.६७ लाख
-३७.४६ लाख
Net interest expenses
६४.०८ लाख
५३.०५ लाख
५०.३३ लाख
२२.५४ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
२.९५ करोड
३.४९ करोड
-२.६१ करोड
-६.६६ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू